No offerings have been identified for this subject in 2017
POD408 Advanced Pharmacology and Prescribing (8)
Abstract
This subject builds on the student's knowledge of pharmacology, to develop an understanding of the issues associated with the prescription, administration and dispensing of medicines. Students will study the clinical use of a range of S2, S3 and S4 medicines of relevance to podiatric practice. Medico-legal and ethical implications of prescribing will be addressed and students will consider their professional responsibilities as a potential prescriber. Areas of study are informed by the prescribing competencies framework and will comprise: understanding the person and their clinical needs; understanding treatment options and how they support the person's clinical needs; working in partnership with the person to develop and implement a treatment plan; communicating the treatment plan clearly to other health professionals; monitoring and reviewing the person's response to treatment. This subject will provide students with a firm foundation from which to apply for endorsement of scheduled medicines and to work towards becoming competent prescribers.
|
|
|
+ Subject Availability Modes and Location
Continuing students should consult the SAL for current offering details prior to contacting their course coordinator: POD408
Where differences exist between the handbook and the SAL, the SAL should be taken as containing the correct subject offering details.
|
|
Subject information| Duration | Grading System | School: |
|---|
| One session | HD/FL | School of Community Health |
|
|
Enrolment restrictions|
Bachelor of Podiatric Medicine and Bachelor of Podiatric Medicine (Honours) |
|
|
| Prerequisite(s) |
|---|
| BMS263 and POD307 and POD308 and POD317 |
|
Learning OutcomesUpon successful completion of this subject, students should:
- be able to evaluate critically the ethical and medico-legal implications, and professional responsibility associated with prescribing medicines;
- be able to evaluate the clinical needs of a broad range of clients with lower limb pathology in order to negotiate therapeutic goals;
- be able to evaluate pharmacological and non-pharmacological treatment options for a client with lower limb pathology;
- be able to justify the use of a range of S2,S3 and S4 medicines in the management of lower limb pathology;
- be able to demonstrate collaborative working with a range of clients to develop and implement appropriate treatment plans;
- be able to evaluate a client's health status to identify possible risks and contraindications for medicines relevant to podiatry practice;
- be able to justify the dosage of medicines for a range of clients, considering personal issues such as age, gender, weight and size;
- be able to explain appropriate monitoring and review processes to assess a client's response to treatment;
- be able to analyse critically the implications to the client and the wider community of prescribing a particular medicine e.g. cost of medicines; use of generic medicines; antibiotic prescribing;
- be able to evaluate the role of interprofessional collaboration in treatment planning, the prescription of medicines and client review;
- be able to evaluate the potential for bias in prescribing decisions e.g. marketing influences, personal values and beliefs, possible financial gain.
|
|
|
SyllabusThe subject will cover the following topics:
- Review of the scheduled medicines list for podiatry
- Review of the drugs and poisons legislation in the states and territories of Australia
- Ethical and medico-legal implications and professional responsibility of prescribing medicines, including prescription writing
- Case based study to include: client assessment; pharmacological and non-pharmacological treatment options; indications and contraindications; pharmacodynamics and pharmacokinetics; adverse drug effects, drug dosage and correct use; monitoring and review, for a range of drugs of relevance to podiatry practice
- Interprofessional working in relation to the prescripton of medicines for clients
- Sociopolitical issues associated with prescription medicines e.g. cost, PBS, private prescriptions; drug companies and marketing
- Potential for bias in prescribing decisions e.g marketing influences, personal values and beliefs, possible financial gain
|
|
|
Work Place Learning| This subject contains a Compulsory Workplace Learning component of 3 days duration.
Students will be expected to interview clients as part of their study for this subject. An allocation of 2 hours/week for 12 weeks will enable students to extend their existing workplace learning experience, to include time for client interviews and mock prescription of medicines. This process will enable students to develop confidence in their ability to make prescribing decisions, for a range of clients with lower limb pathology.
This subject contains a Compulsory Workplace Learning component of 3 days duration.
Students will be expected to interview clients as part of their study for this subject. An allocation of 2 hours/week for 12 weeks will enable students to extend their existing workplace learning experience, to include time for client interviews and mock prescription of medicines. This process will enable students to develop confidence in their ability to make prescribing decisions, for a range of clients with lower limb pathology.
|
|
|
Back
The information contained in the 2017 CSU Handbook was accurate at the date of publication: 12 August 2016. The University reserves the right to vary the information at any time without notice.
